A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation

Published:2024-08 Issue: Volume:200 Page:104403
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Meng Yiming^ORCID,Sun Jing,Zhang Guirong

Publisher

Elsevier BV

Reference102 articles.

1. Microbial biomarkers for immune checkpoint blockade therapy against cancer;Adachi;J. Gastroenterol.,2018

2. A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab;Adusumilli;Cancer Discov.,2021

3. Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer;Awad;Cancer Cell,2022

4. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu Rev. Pathol.,2021

5. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment;Bai;J. Clin. Lab Anal.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature of the Association between Rheumatoid Arthritis and Cervical Cancer and Its Potential Therapeutic Implications;Nutrients;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3